|17th November 2020
In 2018, Blue Latitude Health joined Fishawack Health. As a leading commercialization partner for the life science industry, Fishawack Health’s mission is to shape and affect connections between people and life-enhancing therapies, empowering them with the knowledge and the motivation needed to improve outcomes.
Delta magazine helps us deliver on this mission by sharing our knowledge and exploring opportunities for life science companies to innovate across the drug lifecycle. In each edition of the magazine, our scientific, strategic, and creative experts will share the knowledge they have gained working with trailblazers in the life science industry.
We will also reveal exclusive stories from the stakeholders such as patients and key opinion leaders, and we will shine a light on companies shaping the future of healthcare.
In our first issue, we delve into rare diseases to reveal why rare disease drug development and launch requires a unique business model compared to other disease areas. Our strategic, creative, and scientific experts explore:
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?